50 /100
MEDIUM RISK
Score updated Apr 13, 2026

RNAZ

TransCode Therapeutics, Inc. — Stock Dilution Tracker

Track RNAZ dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track RNAZ — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
20
💰 Cash Runway
85
📊 Float Risk
20
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
30%
🔁 Convertible Conversion 40%
• Significant convertible debt: 16% potential dilution
• Elevated convertible risk (60/100)
💰 Capital Raise 35%
• Low cash runway: 4 months remaining
🔔 Track RNAZ — Get forecast alerts →
💹 Market Data
Market Cap$7.53M
Shares Outstanding917.0K
Float832.4K
Cash$2.84M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 73.1% shares (2025Q4 vs prior)
6 institutional holders · 3.9K shares
#1 UBS Group AG 3.0K shares
#2 Tower Research Capital LLC (TRC) 887 shares
#3 BANK OF AMERICA CORP /DE/ 16 shares
+ 3 more holders Sign up free to view →
📉 Short Interest
Short Interest50.0K
Days to Cover6.1
% of Float6.0%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Mar 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track RNAZ Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RNAZ — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required